Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06395428 · ClinicalTrials.gov registry record · Phase 4
Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department
A Phase 4 study of Chronic Pain and Back Pain, sponsored by Western Michigan University School of Medicine.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT06395428: Recruiting Phase 4 study of Chronic Pain and Back Pain, sponsored by Western Michigan University School of Medicine.
NCT06395428 is a Phase 4 study of Chronic Pain and Back Pain that is actively recruiting participants, run by Western Michigan University School of Medicine. The registered enrollment target is 75 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06395428, a Phase 4 study of Chronic Pain and Back Pain, is actively recruiting participants, sponsored by Western Michigan University School of Medicine.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Single center, double-blind, randomized, controlled trial in patients who present to the emergency department (ED) with a chief complaint of back pain. A total of 150 patients age 18-65 presenting to the emergency department with chief complaint of backpain will be enrolled from April 2024 - April 2025. Patients will be randomized and symptom levels will be recorded at 30, 60, 90, minutes. Follow-up will be performed by telephone at 24 hours.
Primary Outcome
Mean change in visual analog scale (VAS) of self-rated nausea severity
Conditions Studied
Interventions
- DRUG Haloperidol
- DRUG Ketorolac Tromethamine
Study Locations (1)
Michigan
- Bronson Methodist Hospital - Kalamazoo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-07-09 |
| Est. Completion | 2027-04-15 |
| Phase | Phase 4 |
What NCT06395428 shows while recruiting
NCT06395428 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Haloperidol is the first listed.
NCT06395428 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06395428 about?
NCT06395428 is a clinical study titled "Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department". Single center, double-blind, randomized, controlled trial in patients who present to the emergency department (ED) with a chief complaint of back pain. A total of 150 patients age 18-65 presenting to the emergency department with chief complaint of backpain will be enrolled from April 2024 - April 2...
What is the current status of trial NCT06395428?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2024-07-09. Estimated completion is 2027-04-15.
What conditions does trial NCT06395428 study?
This clinical trial studies the following conditions: Chronic Pain, Back Pain.
What interventions are being tested in trial NCT06395428?
The interventions under investigation include: Haloperidol (DRUG), Ketorolac Tromethamine (DRUG).
Who is sponsoring clinical trial NCT06395428?
This trial is sponsored by Western Michigan University School of Medicine, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06395428 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06395428's enrollment target sits among peer trials
75 159th of 301 higher than 140 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow
RECRUITING · Phase 4
-
Stanford Pragmatic Effectiveness Comparison
RECRUITING · Phase 4
-
Better Options for Chronic Cancer Pain
RECRUITING · Phase 4
-
Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment
ACTIVE NOT RECRUITING · Phase 4
-
Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression
ACTIVE NOT RECRUITING · Phase 4
-
PK Sampling After IV Oxytocin and Effects on Sensory Function in Healthy Volunteers
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI